Both hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP) are characterized by thrombotic microangiopathy (TMA), affecting mainly the kidney and brain, respectively. Diagnosis ...

We monitored the levels of various cytokines and chemokines, as well as an adhesion molecule and factors related to vascular endothelial damage, in three patients with thrombotic thrombocytopenic ...

For all primary TMA syndromes, the vascular pathological abnormalities that are observed in routine specimens are the same, as illustrated in the center of the figure by the renal arteriole occlusion ...

Thrombotic thrombocytopenic purpura (TTP) is a rare disorder that affects your blood’s tendency to clot. In this disease, tiny clots form throughout your body. These tiny clots have major consequences ...

An organism provisionally classified as a microtatobiote, order of rickettsiales, family of bartonellaceae, was isolated from two patients with hemolytic-uremic syndrome (HUS) and from another with ...

Mr. R did exhibit four of the five signs, but did not have any neurologic deficits. TTP is often seen in conjunction with hemolytic uremic syndrome (HUS). The incidence of suspected TTP-HUS is 11 ...

Thrombotic microangiopathy due to thrombotic thrombocytopenia should be suspected in a patient with otherwise unexplained thrombocytopenia and anemia, even without fever, renal dysfunction or ...

Plasma exchange is the essential treatment for TTP, but it has no known benefit for patients with cancer-induced or drug-induced TMA. We will describe cancer-induced and drug-induced TMA using the ...

Background: Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are rare disorders characterized by platelet aggregation, microthrombi, and resulting tissue damage. We studied the ...

Microangiopathic Hemolytic Anemia and Thrombocytopenia in Patients With Cancer The following represents disclosure information provided by authors of this manuscript. All relationships are considered ...